Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6986 results

Sort By:

AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Study ID: NCT07027488
Start Date: 2025-08-05
End Date: 2027-08
Study Type

Interventional

Study Phase

Phase1

No. of Participants

50

Intervention / Treatment

AB821

Sponsor

Yale University

Source: clinicaltrials.gov

Share:
Add to list

Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.

Study ID: NCT05948943
Start Date: 2023-11-24
End Date: 2033-05-02
Study Type

Interventional

Study Phase

Phase3

No. of Participants

232

Intervention / Treatment

Alpelisib

Placebo

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer

Study ID: NCT05566574
Start Date: 2022-09-30
End Date: 2026-09-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

84

Intervention / Treatment

RP-3500

External Beam Radiotherapy (EBRT)

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Neoadjuvant Tebentafusp for Uveal Melanoma

Study ID: NCT06414590
Start Date: 2025-09-05
End Date: 2032-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

19

Intervention / Treatment

Tebentafusp-Tebn

Sponsor

Thomas Jefferson University

Source: clinicaltrials.gov

Share:
Add to list

The University of Miami Adapt (UAdapt) Trial

Study ID: NCT06111313
Start Date: 2024-11-06
End Date: 2033-11-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

130

Intervention / Treatment

FTLEAD

Ultra-Short-Term Androgen Deprivation Therapy with Relugolix

HypoLEAD

ADT Standard of Care

Sponsor

University of Miami

Source: clinicaltrials.gov

Share:
Add to list

Pharmacogenetic Determinants Of Treatment Response In Children

Study ID: NCT00730678
Start Date: 1998-08-17
End Date: 2034-03
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

8800

Intervention / Treatment
Sponsor

St. Jude Children's Research Hospital

Source: clinicaltrials.gov

Share:
Add to list

Machine Learning Approaches to Personalized Therapy for Advanced Non-small Cell Lung Cancer With Real-World Data

Study ID: NCT06934343
Start Date: 2024-09-01
End Date: 2026-03
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

144400

Intervention / Treatment
Sponsor

University of Utah

Source: clinicaltrials.gov

Share:
Add to list

Pre-Operative Guided Meditation to Reduce Pre-Operative Anxiety in Patients Undergoing Cancer-Directed Surgery

Study ID: NCT06949943
Start Date: 2025-03-14
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Behavioral Intervention

Behavioral Intervention

Electronic Health Record Review

Survey Administration

Sponsor

Ohio State University Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

LMY-920 for Treatment of Relapsed or Refractory Myeloma

Study ID: NCT05546723
Start Date: 2024-03-13
End Date: 2025-10-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

Autologous CAR-T cell therapy expressing the BAFF-ligand.

Sponsor

Luminary Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade

Study ID: NCT03474497
Start Date: 2019-05-20
End Date: 2023-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

45

Intervention / Treatment

IL-2

Pembrolizumab

Radiotherapy

Sponsor

Megan Daly, MD

Source: clinicaltrials.gov

Share:
Add to list